Journal article
25 years of biologic DMARDs in rheumatology
- Abstract:
-
2023 marks 25 years since the approval of the first biologic drug in rheumatology. In this Viewpoint, five rheumatology researchers discuss how biologic therapy has transformed clinical practice, reflecting on their own experience, past and current challenges and what the future might hold for biologic drugs.
- Publication status:
- Published
Actions
Access Document
- Publisher copy:
- 10.1038/s41584-023-01036-x
Authors
- Publisher:
- Springer Nature
- Journal:
- Nature Reviews Rheumatology More from this journal
- Volume:
- 19
- Issue:
- 12
- Pages:
- 761-766
- Publication date:
- 2023-11-02
- Acceptance date:
- 2023-09-20
- DOI:
- EISSN:
-
1759-4804
- ISSN:
-
1759-4790
- Pmid:
-
37919339
- Language:
-
English
- Keywords:
- Pubs id:
-
1562555
- Local pid:
-
pubs:1562555
- Deposit date:
-
2026-02-04
- ARK identifier:
Terms of use
- Copyright holder:
- Springer Nature Limited
- Copyright date:
- 2023
- Rights statement:
- Copyright © 2023, Springer Nature Limited
If you are the owner of this record, you can report an update to it here: Report update to this record